Discipline of Urology, Faculdade de Medicina do ABC, Santo André, Brazil.
Discipline of Urology, Faculdade de Medicina do ABC, Santo André, Brazil.
J Sex Med. 2020 Apr;17(4):688-694. doi: 10.1016/j.jsxm.2019.12.024. Epub 2020 Jan 30.
Erectile dysfunction (ED) after radical prostatectomy (RP) still represents a major issue. Considering the benefits recently described regarding the application of low-intensity extracorporeal shockwave therapy (LiESWT) in vasculogenic ED, questions arise about its role in the scenario of penile rehabilitation.
To compare the early introduction of phosphodiesterase-5 inhibitor (PDE5i) with a combination therapy enrolling both early PDE5i use and LiESWT in patients submitted to RP.
This study is a randomized clinical trial, open-label, with 2 parallel arms and an allocation ratio of 1:1. The study was registered in ReBEC (ensaiosclinicos.gov.br) Trial: RBR-85HGCG. Both arms started tadalafil at a dose of 5 mg/day right after the removal of the transurethral catheter, and the experimental group received 2,400 shocks/session-week distributed on 4 different penile regions. The full treatment consisted of 19,200 impulses across 8 weeks.
The primary clincal end point was ≥4-point difference favoring the experimental group considering the mean International Index of Erectile Function short form (IIEF-5) at last follow-up. Any statistical difference in the IIEF-5 score between the arms was stated as the primary statistical end point.
Between September 25, 2017, and December 3, 2018, 92 men were enrolled in the study. At last follow-up, we assessed 77 patients, 41 in the control group and 36 in the intervention group. A difference between groups was detected when accessing the final median IIEF-5 score (12.0 vs 10.0; P = .006). However, the primary clinical endpoint considering a difference ≥4-point between the arms has not been reached. When performing an exploratory analysis comparing the proportion of those individuals with an IIEF-5 score ≥17, no difference between groups was noted (17.1% vs 22.2%; P = .57).
So far, the benefits arising from LiESWT for penile rehabilitation after RP have been uncertain.
STRENGTHS & LIMITATIONS: This is the first trial assessing the role of LiESWT on erectile function after RP. Our study protocol included only one session per week for the experimental group, raising a query if a more intensive application could achieve better results once a statistically significant difference was found between groups. We discontinue the PDE5i use at the last session, which may have interfered in the penile vascular rehabilitation, maybe compromising the results too.
After therapy with 19,200 impulses therapy across 8 weeks, we found an improvement of the IIEF-5 score, but it was not enough to be considered clinically significant. More studies are warranted before any recommendation on this topic. Baccaglini W, Pazeto CL, Corrêa Barros EA, et al. The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial. J Sex Med 2020;17:688-694.
根治性前列腺切除术后(RP)的勃起功能障碍(ED)仍然是一个主要问题。考虑到最近描述的低强度体外冲击波治疗(LiESWT)在血管性 ED 中的应用的益处,人们对其在阴茎康复中的作用产生了疑问。
比较在接受 RP 的患者中,早期使用磷酸二酯酶-5 抑制剂(PDE5i)与同时早期使用 PDE5i 和 LiESWT 的联合治疗的效果。
这是一项随机临床试验,开放性标签,有 2 个平行组,分配比例为 1:1。研究在 ReBEC(ensaiosclinicos.gov.br)试验中进行:RBR-85HGCG。两组患者均在经尿道导管取出后立即开始服用 5mg/天的他达拉非,实验组接受 2400 次/次/周的 4 个不同阴茎区域分布的冲击。整个治疗过程共进行 8 周,共 19200 次冲击。
主要临床终点是最后随访时实验组 IIEF-5 平均得分(IIEF-5)较对照组至少高出 4 分。两组之间 IIEF-5 评分的任何统计学差异均被定义为主要统计学终点。
在接受 19200 次冲击治疗 8 周后,我们发现 IIEF-5 评分有所改善,但还不足以被认为具有临床意义。在这一主题上提出任何建议之前,还需要进行更多的研究。